Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03739554 |
| Title | CYC065 CDK Inhibitor and Venetoclax Study in Relapsed/Refractory CLL |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Cyclacel Pharmaceuticals, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Investigational Site | Baltimore | Maryland | 21201 | United States | Details | |
| Investigational Site | Charlotte | North Carolina | 28204 | United States | Details | |
| Investigational Site | Houston | Texas | 77030 | United States | Details |